Desenvolvimento e validação de metodologia para avaliação de fluticasona por cromatografia líquida e eletroforese capilar

• Autor(a) principal: Sangoi, Maximiliano da Silva
• Data de Publicação: 2009
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Manancial - Repositório Digital da UFSM
• Texto Completo: http://repositorio.ufsm.br/handle/1/5886
• topic: Cromatografia líquida; Eletroforese capilar; Formulações farmacêuticas; Propionato de fluticasona; Validação; Capillary electrophoresis; Fluticasone propionate; Liquid chromatography; Pharmaceutical formulations; Validation; CNPQ::CIENCIAS DA SAUDE::FARMACIA

Fluticasone propionate (FP) is a synthetic glucocorticoid with potent anti-inflammatory activity that has been effectively used for the treatment of seasonal and allergic perennial rhinitis, minimizing systemic activity. In the present study, the methods were developed and validaded for assessment of FP in pharmaceutical products. The analysis by reversed-phase liquid chromatography were performed using Shim-pack CLC-ODS column (150 x 4.6 mm), maintained at 35 °C. The mobile phase was consisted of acetonitrile/ methanol/ 0.01M phosphate buffer pH 4 (35:35:30), run at flow rate of 1 mL/min and using photodiode array detection at 240 nm. The chromatographic separation was obtained within 8 minutes and it was linear in the concentration range of 0.05-150 μg/mL (r2 = 0,9999). The method was successfully applied for the determination of FP in creams and nasal sprays pharmaceutical formulations. The micellar electrokinetic chromatography was also developed and validaded. The analyses were performed on a fused-silica capillary (50 μm i.d.; effective length, 40 cm) and background electrolyte consisted of 25 mM borate and 25mM SDS solution at pH 9. The capillary temperature was maintained at 35 °C and the applied voltage was 20 kV. The injection was performed using the hydrodynamic mode at 50 mbar for 6 s, with detection at 238 nm. The electrophoretic separation was obtained with migration time of 5.6 and 5.1 minutes for the FP and prednisolone acetate (internal standard), respectively, and with run time of 7 minutes. The method was linear in the concentration range of 2-80 μg/mL (r2 = 0.9956). The procedures were validated evaluating parameters such as the specificity, linearity, precision, accuracy, and robustness, limit of detection and limit of quantitation, whose results have met the requirements recommended. The proposed methods were used for the analysis of pharmaceutical products, demonstrating nonsignificative difference of the results (P > 0.05). Then, the procedures contribute to improve the quality control, assuring the safety and therapeutic efficacy of pharmaceutical formulations.